Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on
top health stories.
Study: Diabetic heart attacks and strokes falling
16 Apr 2014 at 5:56pm
NEW YORK (AP) ? In the midst of the diabetes epidemic, a glimmer of good news: Heart attacks, strokes and other complications from the disease are plummeting.
Ebola virus in Africa outbreak is a new strain
16 Apr 2014 at 2:33pm
The Ebola virus that has killed scores of people in Guinea this year is a new strain ? evidence that the disease did not spread there from outbreaks in some other African nations, scientists report.
Study finds signs of brain changes in pot smokers
15 Apr 2014 at 3:07pm
NEW YORK (AP) ? A small study of casual marijuana smokers has turned up evidence of changes in the brain, a possible sign of trouble ahead, researchers say.
Obama budget plan would boost U.S. tax revenues, cut deficits: CBO
17 Apr 2014 at 7:56am
President Barack Obama's fiscal 2015 budget request would boost U.S. tax revenues by nearly $1.4 trillion over 10 years if fully enacted, slashing deficits by $1.05 trillion while funding new spending, the Congressional Budget Office said on Thursday. There is virtually no chance that Congress will advance Obama's plan in its entirety. But the CBO's latest analysis will feed campaign messaging by both Democrats and Republicans ahead of congressional elections in November. The analysis compares Obama's request to a new "baseline" estimate that CBO released last week that assumes no changes to current tax and spending laws.
Teva, Pfizer settle patent lawsuit over blockbuster painkiller
17 Apr 2014 at 7:48am
(Reuters) - Teva Pharmaceutical Industries Ltd said it settled a patent lawsuit with Pfizer Inc, allowing the Israeli drugmaker to launch a generic version of Pfizer's blockbuster painkiller Celebrex in December. In March, a U.S. court invalidated a patent covering Celebrex, giving Pfizer's rivals a chance to sell cheaper versions. Pfizer had said it would appeal the ruling. The drug, which is used to treat arthritis pain and inflammation, generated about $2.92 billion in sales in 2013, according to Pfizer's annual regulatory filing.
GE industrial profit boost underscores strategy, shares up
17 Apr 2014 at 7:39am
General Electric Co posted a 12 percent rise in overall industrial profits on Thursday, as strength in its businesses selling gas turbines, jet engines and oil industry equipment offset weakness in healthcare and transportation. GE, which is increasingly focusing on its traditional manufacturing businesses over its finance unit, posted an 8 percent increase in industrial revenue, even as overall company revenue fell slightly short of Wall Street's target. "The big story is the organic revenue growth," said Tim Ghriskey, chief investment officer of Solaris Asset Management, which owns GE shares. "It really shows the return to an industrial emphasis is paying off, and where the company is focusing." The results underscored GE Chief Executive Officer Jeff Immelt's strategy to focus the company even more on manufacturing of large industrial products as he reduces the company's dependence on its GE Capital finance unit.
Conjoined Twins See Sunlight For the First Time
17 Apr 2014 at 7:01am
They were finally able to go outside, seven months after surgery.
GSK, facing bribery claims, battles to build new sales model
17 Apr 2014 at 6:41am
Following a decision to cut commercial ties with outside doctors, GSK expects to increase its in-house team of physicians by 10-20 percent over the next year or so from around 1,500 at present, Chief Medical Officer James Shannon told Reuters. GSK is now investigating claims that bribes were paid to doctors in Poland, Iraq, Jordan and Lebanon, following a much larger case of alleged bribery in China. Chinese authorities in July accused GSK of funneling up to 3 billion yuan ($483 million) to doctors and officials to encourage them to use its medicines in a case that the company has described as "shameful". The firm aims to become the first in the industry to stop paying outside doctors to promote its products, end payments for medics to attend conferences and delink incentives for sales representatives from individual sales targets.
China backs away from price controls on basic drugs
17 Apr 2014 at 6:38am
By Li Hui and Adam Jourdan BEIJING/SHANGHAI (Reuters) - China has backtracked on its policy of capping retail prices on medicines and will allow pharmaceutical companies to set prices for some drugs, after criticism that controls had caused a drug drought that derailed treatment for millions of patients. Beijing has been struggling with rising healthcare costs, violent conflicts between patients and doctors and medicine safety issues, and President Xi Jinping has said providing affordable, accessible healthcare is a government priority. The partial reversal of the price control policy, in an announcement quietly posted on a government website on Tuesday, will give drug companies that were reluctant to supply low-cost medicines greater incentives to do so and likely ease shortages. But the move is limited to a specific number of drugs and falls short of tackling the official price controls that have placed undue price pressures on the pharmaceutical industry.
Death toll from Guinea Ebola outbreak rises to 122
17 Apr 2014 at 5:54am
CONAKRY (Reuters) - The death toll from an Ebola outbreak in Guinea has risen to 122, the World Health Organisation said on Thursday, a sharp increase from a previous figure of 108. The disease has spread from Guinea's remote southeast to the capital, Conakry, where 16 people have died. It has also crossed into Liberia but the number of dead there blamed on Ebola remains 13, the figures show. Samples tested in Mali, Ghana and Sierra Leone have been negative so far but governments in the region have restricted flights, closed some borders and imposed health checks in some airports.
UnitedHealth says first-quarter profit fell on reform costs
17 Apr 2014 at 5:40am
(Reuters) - UnitedHealth Group Inc , the largest U.S. health insurer, said on Thursday that first-quarter profit fell due to costs and taxes related to the national healthcare reform law as well as government cuts to private Medicare funding. The company said the costs related to the Affordable Care Act and the effects of budget sequestration last year on payments from the government negatively affected earnings by about 35 cents per share. Its Optum technology-related division, which has worked on the online insurance exchanges created by that reform law, continued to grow. UnitedHealth said net profit was $1.1 billion, or about $1.10 per share, compared with $1.2 billion, or $1.16 per share a year earlier.
Dying Boy Who Got Unapproved Drug Leaves Hospital
17 Apr 2014 at 5:28am
Josh Hardy was dying last month, but has now left the hospital.
A year after marathon bombs, Boston hospitals apply lessons learned
17 Apr 2014 at 5:03am
By Svea Herbst-Bayliss BOSTON (Reuters) - The homemade bombs that ripped through the crowd at the finish line of last year's Boston Marathon, killing three people and injuring 264, showcased the city's medical talent but also taught valuable lessons in responding to a mass disaster. By all accounts, Boston's hospitals performed well after the attacks on April 15, 2013. Looking back, a year after their hospitals were packed with blast victims, Boston officials have tweaked how they prepare for a disaster, now requiring city emergency medical personnel to carry tourniquets and developing a standard method for one city agency to track disaster victims in hospitals.
Portland plans reservoir flush after teen cited
17 Apr 2014 at 4:23am
PORTLAND, Ore. (AP) ? Call it the Big Flush 2, and this time the sequel promises to be much bigger than the original.
Instant View: GE industrial earnings rise, shares tick higher
17 Apr 2014 at 4:21am
GE, which is increasingly focusing on its traditional manufacturing businesses over its finance unit, posted an 8 percent increase in industrial revenue, even as overall company revenue fell slightly short of Wall Street's target. They have still three quarters to get above zero in terms of what they guided for the year." PERRY ADAMS, NORTHWESTERN BANK, TRAVERSE CITY, MICHIGAN, MANAGES GE SHARES "They beat expectations by a penny, but it definitely was a mixed bag.